Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Teresa Cibeira

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Acta Oncologica (Stockholm, Sweden)|August 25, 2005
Bortezomib: a valuable new antineoplastic strategy in multiple myelomaJoan Bladé, M Teresa Cibeira, Laura Rosiñol
Seminars in Hematology|April 25, 2009
Management of complications in multiple myelomaEvangelos Terpos, M Teresa Cibeira, Joan Blade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Multiple myelomaJ Bladé, M Teresa Cibeira, C Fernández de Larrea, et al.
European Journal of Haematology|September 19, 2006
Long-term results of thalidomide in refractory and relapsed multiple myeloma with emphasis on response durationM Teresa Cibeira, Laura Rosiñol, Laia Ramiro, et al.
Hematology. American Society of Hematology. Education Program|December 7, 2024
Neurological manifestations of MGUSM Teresa Cibeira, Luis Gerardo Rodríguez-Lobato, Aida Alejaldre, et al.
Acta Haematologica|October 4, 2006
Bortezomib-induced rhabdomyolysis in multiple myelomaM Teresa Cibeira, Santiago Mercadal, Leonor Arenillas, et al.
European Journal of Haematology|December 14, 2005
Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myelomaCésar Samanez, Abel Domingo, M Teresa Cibeira, et al.
Mayo Clinic Proceedings|April 10, 2007
Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein sizeLaura Rosiñol, M Teresa Cibeira, Silvia Montoto, et al.
Cytokine|January 8, 2008
Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agentsM Teresa Cibeira, María Rozman, Marta Segarra, et al.
Acta Haematologica|April 3, 2020
Supportive Care in AL AmyloidosisM Teresa Cibeira, José T Ortiz-Pérez, Luis F Quintana, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Acta Oncologica (Stockholm, Sweden)|August 25, 2005
Bortezomib: a valuable new antineoplastic strategy in multiple myelomaJoan Bladé, M Teresa Cibeira, Laura Rosiñol
Seminars in Hematology|April 25, 2009
Management of complications in multiple myelomaEvangelos Terpos, M Teresa Cibeira, Joan Blade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Multiple myelomaJ Bladé, M Teresa Cibeira, C Fernández de Larrea, et al.
European Journal of Haematology|September 19, 2006
Long-term results of thalidomide in refractory and relapsed multiple myeloma with emphasis on response durationM Teresa Cibeira, Laura Rosiñol, Laia Ramiro, et al.
Hematology. American Society of Hematology. Education Program|December 7, 2024
Neurological manifestations of MGUSM Teresa Cibeira, Luis Gerardo Rodríguez-Lobato, Aida Alejaldre, et al.
Acta Haematologica|October 4, 2006
Bortezomib-induced rhabdomyolysis in multiple myelomaM Teresa Cibeira, Santiago Mercadal, Leonor Arenillas, et al.
European Journal of Haematology|December 14, 2005
Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myelomaCésar Samanez, Abel Domingo, M Teresa Cibeira, et al.
Mayo Clinic Proceedings|April 10, 2007
Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein sizeLaura Rosiñol, M Teresa Cibeira, Silvia Montoto, et al.
Cytokine|January 8, 2008
Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agentsM Teresa Cibeira, María Rozman, Marta Segarra, et al.
Acta Haematologica|April 3, 2020
Supportive Care in AL AmyloidosisM Teresa Cibeira, José T Ortiz-Pérez, Luis F Quintana, et al.
Pageof 4